Lv31
322 积分 2025-02-23 加入
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)
14分钟前
已完结
Diagnostic utility of serum and urine biomarkers in idiopathic membranous nephropathy: a systematic review and meta-analysis
19分钟前
已完结
Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy
27分钟前
已完结
[Expert consensus on the application of rituximab in the treatment of membranous nephropathy]
43分钟前
已完结
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
52分钟前
已完结
Antigens in membranous nephropathy: discovery and clinical implications
1小时前
已完结
Updated diagnostic and therapeutic management for membranous nephropathy
1小时前
已完结
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial
1小时前
已完结
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
1小时前
已完结
STING1 exacerbates iodinated contrast-induced acute kidney injury by promoting ferroptosis through chaperone-mediated autophagic degradation of FTH1
2个月前
已完结
皖公网安备34019202002308
